Literature DB >> 18019028

Chromosome variability of human multipotent mesenchymal stromal cells.

N P Bochkov1, E S Voronina, N V Kosyakova, T Liehr, A A Rzhaninova, L D Katosova, V I Platonova, D V Gol'dshtein.   

Abstract

We elaborated a method of preparing cytogenetic preparations of cultured multipotent mesenchymal stromal cells from the adipose tissue. It was found that karyotypic changes (monosomy, translocations) appear in some samples during culturing. Clones with changed karyotype were detected in 11-14-passage cultures from 2 of 7 individuals. The percent of aberrant cells in cultures from different individuals varied from 1.5 to 5.95 per 100 cells, which attested to karyotype instability. These data substantiate the need for cytogenetic control of cells before their transplantation into donor organism and further investigation of chromosome variability in stem cells.

Entities:  

Mesh:

Year:  2007        PMID: 18019028     DOI: 10.1007/s10517-007-0031-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  9 in total

1.  Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy.

Authors:  R Binato; T de Souza Fernandez; C Lazzarotto-Silva; B Du Rocher; A Mencalha; L Pizzatti; L F Bouzas; E Abdelhay
Journal:  Cell Prolif       Date:  2012-11-16       Impact factor: 6.831

2.  Cytogenetic instability of dental pulp stem cell lines.

Authors:  Monica Talarico Duailibi; Leslie Domenici Kulikowski; Silvio Eduardo Duailibi; Monica Vannucci Nunes Lipay; Maria Isabel Melaragno; Lydia Masako Ferreira; Joseph Phillip Vacanti; Pamela Crotty Yelick
Journal:  J Mol Histol       Date:  2011-11-23       Impact factor: 2.611

Review 3.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

4.  Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints.

Authors:  Jaewoo Pak; Jae-Jin Chang; Jung Hun Lee; Sang Hee Lee
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

5.  Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media.

Authors:  Myung-Suk Lee; Christine Youn; Jeong Hyun Kim; Byoung Jun Park; Jongchan Ahn; Sungyoul Hong; Young-Deug Kim; Young Kee Shin; Sang Gyu Park
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

Review 6.  Impact of Age on Human Adipose Stem Cells for Bone Tissue Engineering.

Authors:  Denis Dufrane
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

7.  GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels.

Authors:  Ana Belén Carrillo-Gálvez; Sheyla Gálvez-Peisl; Juan Elías González-Correa; Marina de Haro-Carrillo; Verónica Ayllón; Pedro Carmona-Sáez; Verónica Ramos-Mejía; Pablo Galindo-Moreno; Francisca E Cara; Sergio Granados-Principal; Pilar Muñoz; Francisco Martin; Per Anderson
Journal:  Stem Cells Transl Med       Date:  2020-02-19       Impact factor: 6.940

8.  Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation.

Authors:  Y Wang; Z Zhang; Y Chi; Q Zhang; F Xu; Z Yang; L Meng; S Yang; S Yan; A Mao; J Zhang; Y Yang; S Wang; J Cui; L Liang; Y Ji; Z-B Han; X Fang; Z C Han
Journal:  Cell Death Dis       Date:  2013-12-05       Impact factor: 8.469

Review 9.  Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.

Authors:  Juan Antonio Guadix; Javier López-Beas; Beatriz Clares; José Luis Soriano-Ruiz; José Luis Zugaza; Patricia Gálvez-Martín
Journal:  Pharmaceutics       Date:  2019-10-24       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.